Abstract |
Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,03, 11,05, 9] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model ( acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals.
|
Authors | S G Krylova, T N Povet'eva, E P Zueva, N I Suslov, E N Amosova, T G Razina, K A Lopatina, O Yu Rybalkina, Yu V Nesterova, O G Afanas'eva, E A Kiseleva, S V Sysolyatin, D A Kulagina, V V Zhdanov |
Journal | Bulletin of experimental biology and medicine
(Bull Exp Biol Med)
Vol. 166
Issue 4
Pg. 461-465
(Feb 2019)
ISSN: 1573-8221 [Electronic] United States |
PMID | 30788739
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Analgesics
(therapeutic use)
- Animals
- Disease Models, Animal
- Gastric Mucosa
(drug effects)
- Male
- Mice
- Naloxone
(therapeutic use)
- Pain
(drug therapy, physiopathology)
- Pain Measurement
(methods)
|